
### [MONDO:0019508](http://purl.obolibrary.org/obo/MONDO_0019508)
**Label:** van der Woude syndrome

**Subclasses:** [MONDO:0007333](http://purl.obolibrary.org/obo/MONDO_0007333) (van der Woude syndrome 1), [MONDO:0011712](http://purl.obolibrary.org/obo/MONDO_0011712) (van der Woude syndrome 2), 

**Mapped go classes:** [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0090179](http://purl.obolibrary.org/obo/GO_0090179) (planar cell polarity pathway involved in neural tube closure), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0060429](http://purl.obolibrary.org/obo/GO_0060429) (epithelium development), [GO:0007398](http://purl.obolibrary.org/obo/GO_0007398) (ectoderm development), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0060644](http://purl.obolibrary.org/obo/GO_0060644) (mammary gland epithelial cell differentiation), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0043616](http://purl.obolibrary.org/obo/GO_0043616) (keratinocyte proliferation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0090103](http://purl.obolibrary.org/obo/GO_0090103) (cochlea morphogenesis), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0061029](http://purl.obolibrary.org/obo/GO_0061029) (eyelid development in camera-type eye), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0032956](http://purl.obolibrary.org/obo/GO_0032956) (regulation of actin cytoskeleton organization), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0001736](http://purl.obolibrary.org/obo/GO_0001736) (establishment of planar polarity), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0071466](http://purl.obolibrary.org/obo/GO_0071466) (cellular response to xenobiotic stimulus), 

**Class expressions from DL-Learner:**

- [GO:0090103](http://purl.obolibrary.org/obo/GO_0090103) (cochlea morphogenesis) 53.57%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 53.57%
- [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier) 53.57%
- [GO:0061029](http://purl.obolibrary.org/obo/GO_0061029) (eyelid development in camera-type eye) 53.57%
- [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis) 53.57%
- [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis) 53.57%
- [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis) 53.57%
- [GO:0043616](http://purl.obolibrary.org/obo/GO_0043616) (keratinocyte proliferation) 53.57%
- [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development) 53.57%
- [GO:0033561](http://purl.obolibrary.org/obo/GO_0033561) (regulation of water loss via skin) 53.57%
- [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development) 53.57%
- [GO:0007398](http://purl.obolibrary.org/obo/GO_0007398) (ectoderm development) 53.57%
- [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure) 53.57%
- Thing 52.39%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 45.68%


